Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000061

Chief Medical Officer sold 5,026 shares at $15.00 ($75,398)

  • Chief Medical Officer acquired 10,043 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2024-11-11 Option exercise 10b5-1 +5,017 $0.54 $2,709 140,991 D
Rodman David Malcom Chief Medical Officer 2024-11-11 Option exercise 10b5-1 +5,026 $1.08 $5,428 146,017 D
Rodman David Malcom Chief Medical Officer 2024-11-11 Sale 10b5-1 −5,026 $15.00 $75,398 140,991 D
Derivatives
Rodman David Malcom Chief Medical Officer 2024-11-11 Option exercise · Stock Option 10b5-1 −5,017 10,035 D
Rodman David Malcom Chief Medical Officer 2024-11-11 Option exercise · Stock Option 10b5-1 −5,026 134,926 D
Open-market sales · 5,026 sh · avg $15.00 · $75,398
Loading xslF345X05/wk-form4_1731450331.xml…